PI
AGN

PFS Investments’s Allergan plc AGN Stock Holding History

PFS Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21,705
Closed -$3.84M – 288
2020
Q1 		$3.84M Buy
21,705
+4,615
+27% +$869K 0.17% 98
2019
Q4 		$3.27M Buy
17,090
+2,354
+16% +$425K 0.13% 117
2019
Q3 		$2.48M Buy
14,736
+5,150
+54% +$839K 0.11% 112
2019
Q2 		$1.61M Buy
9,586
+6,468
+207% +$896K 0.07% 111
2019
Q1 		$457K Buy
+3,118
New +$452K 0.02% 124

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

PFS Investments's AGN Position: Q2 2020 in Review

PFS Investments sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 21,705 shares — an estimated $3.84M sold.

PFS Investments first reported a position in AGN in Q1 2019 and held it in 5 quarters. The position peaked at $3.84M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • PFS Investments reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • PFS Investments sold 21,705 Allergan plc shares in Q2 2020, an estimated $3.84M.
  • PFS Investments first reported a position in Allergan plc in Q1 2019 and held it in 5 quarters.
  • PFS Investments's Allergan plc position peaked at $3.84M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on PFS Investments's 13F filing for Q2 2020, filed 14 Aug 2020.